^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    brontictuzumab (OMP-52M51)

    i
    Associations
    News

    Trials

    Company:
    Mereo Biopharma
    Drug class:
    Notch inhibitor, Stem cell inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer (NCT03031691)
    Phase 1b
    OncoMed Pharmaceuticals, Inc.
    Completed
    Last update posted :
    08/11/2020
    Initiation :
    01/01/2017
    Primary completion :
    05/01/2017
    Completion :
    09/01/2017
    KRAS
    |
    KRAS wild-type • RAS wild-type
    |
    Lonsurf (trifluridine/tipiracil) • brontictuzumab (OMP-52M51)